内分泌检测产品市场：依产品类型、技术、适应症、最终用户和地区划分

2025 年全球内分泌检测产品市场规模估计为 149.8 亿美元，预计到 2032 年将达到 281.1 亿美元，2025 年至 2032 年的复合年增长率为 9.4%。

图。

内分泌检测产品是用于检测内分泌系统功能的体外诊断产品。内分泌系统是由腺体组成的调节系统，腺体直接分泌荷尔蒙进入血液循环，以调节远处的目标器官。内分泌测试产品可帮助医生监测荷尔蒙水平并筛检内分泌失调。常见的内分泌检查有甲状腺功能检查、睪固酮检查、雌激素检查、催乳素检查、皮质醇检查、胰岛素检查等。糖尿病、甲状腺疾病和荷尔蒙失调等内分泌相关疾病的盛行率不断上升，可能会推动全球对内分泌检测的需求。诊断技术的进步促进了高灵敏度生物检测和自动化解决方案的开发，可用于临床实验室的高性能内分泌测试。

市场动态

全球内分泌检测产品市场的成长得益于老年人口的增加，老年人更容易患上内分泌疾病，对内分泌疾病的认识和筛检不断增加，以及内分泌功能测试在疾病诊断和管理中的应用不断扩大。然而，新产品核可的漫长而复杂的监管过程以及不愿修改现有测试程序可能会阻碍市场的成长。市场看到了从先进的免疫检测平台的开发中获得的丰厚机会，这些平台具有更高的准确性、更高的测试量和整合的资讯学。这样就可以使用小样本同时测试多种荷尔蒙。

研究的主要特点

本报告对全球内分泌检测产品市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球内分泌检测产品市场的主要企业已根据公司亮点、产品系列、关键亮点、性能和策略等参数进行了分析。

研究涉及的主要企业包括雅培、AB Sciex、安捷伦科技公司、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、丹纳赫、Immunodiagnostic Systems 和 Fujirebio, Inc.

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球内分泌检测产品市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员将透过全球内分泌检测产品市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购情景
• 流行病学
• 管道分析

4. 内分泌检测产品市场依产品类型划分，2020-2032 年（十亿美元）

• 介绍
• 仪器/分析设备
• 耗材

5. 内分泌检测产品市场（依技术划分），2020-2032 年（十亿美元）

• 介绍
• 液相层析法质谱法
• 免疫检测
• 串联式质谱质谱法
• 感测器技术
• 其他的

6. 内分泌检测产品市场（依疾病适应症划分），2020-2032 年（十亿美元）

• 介绍
• 肾上腺功能不全和爱迪生氏症
• 骨病
• 癌症
• 甲状腺疾病
• 其他的

7. 内分泌检测产品市场（以最终用户划分），2020-2032 年（十亿美元）

• 介绍
• 医院
• 临床实验室
• 其他的

8. 内分泌检测产品市场，按地区，2020-2032 年（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• Abbott
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• F.Hoffmann-La Roche Ltd.
• Quest Diagnostics Inc
• Danaher
• Immunodiagnostic Systems
• Fujirebio, Inc.

第 10 章分析师建议

• 兴衰
• 一致的机会地图

第 11 章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Endocrine Testing Product Market is estimated to be valued at USD 14.98 Bn in 2025 and is expected to reach USD 28.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.

Figure. Endocrine Testing Product Market Share (%), By Region 2025

Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.

Market Dynamics

Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.

Key Features of the Study

This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global endocrine testing product market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market

Market Segmentation

• By Product Type Insights
  • Instruments/Analyzers
  • Consumables
• By Technology Insights
  • Liquid Chromatography-Mass Spectrometry
  • Immunoassay
  • Tandem Mass Spectroscopy
  • Sensor Technology
  • Others
• By Disease Indication Insights
  • Adrenal Insufficiency and Addison Disease
  • Bone Disorders
  • Cancer
  • Thyroid Disease
  • Others
• By End User Insights
  • Hospitals
  • Clinical Laboratories
  • Others
• Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Endocrine Testing Product Market, By Product Type
  • Endocrine Testing Product Market, By Technology
  • Endocrine Testing Product Market, By Disease Indication
  • Endocrine Testing Product Market, By End User
  • Endocrine Testing Product Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Epidemiology
• Pipeline Analysis

4. Endocrine Testing Product Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Instruments/Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Endocrine Testing Product Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Liquid Chromatography-Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tandem Mass Spectroscopy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sensor Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Endocrine Testing Product Market, By Disease Indication, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adrenal Insufficiency and Addison Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bone Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thyroid Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Endocrine Testing Product Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Endocrine Testing Product Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Inc
• Danaher
• Immunodiagnostic Systems
• Fujirebio, Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us